Translational hurdles in anti-asthmatic nanomedicine development

Expert Opin Drug Deliv. 2024 Jul;21(7):987-989. doi: 10.1080/17425247.2024.2385092. Epub 2024 Jul 28.

Authors

Muhammad Waseem Akram^{1

2}, Tin Wui Wong^{1

2

3}

Affiliations

¹ Non-Destructive Biomedical and Pharmaceutical Research Centre, Smart Manufacturing Research Institute, Universiti Teknologi MARA Selangor, Puncak Alam, Malaysia.
² Particle Design Research Group, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, Puncak Alam, Selangor, Malaysia.
³ Sino-Malaysia Molecular Oncology and Traditional Chinese Medicine Delivery Joint Research Centre, Medical College, Yangzhou University, Yangzhou, China.

PMID: 39045614
DOI: 10.1080/17425247.2024.2385092

No abstract available

Keywords: Asthma; dry powder inhaler; inflammation; nanomedicine; pulmonary delivery.

Publication types

Editorial

MeSH terms

Animals
Anti-Asthmatic Agents* / administration & dosage
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Drug Delivery Systems*
Drug Development*
Humans
Nanomedicine*
Nanoparticles
Translational Research, Biomedical

Substances

Anti-Asthmatic Agents